Clinical trials of the drug are now beginning at home, but patients have been treated with it in the past. Patients with moderate coronavirus infections treated in the hospital recover faster from the drug.

At the Szent László Hospital, the Avigan tablet containing favipiravir has been used in more than 100 patients, which means that patients are cured sooner and do not experience special side effects, János Szlávik told the Hungarian Nation.

The chief physician of the Department of Infectious Diseases at St. Ladislaus Hospital said that in December last year, when the epidemic broke out in China, favipiravir was also used to treat new types of coronavirus patients, and the positive experience led to tests in all the world.

The chief physician also said that the active substance improved in the first 5 to 6 days of the onset of illness in hospitalized patients with moderate conditions who had a fever earlier than favipiravir and were less likely to be admitted to the intensive care unit. .

Another advantage of Avigan is that it is taken orally, but in relatively large amounts: eight eyes should be taken twice the first day and three times twice the second day, and they should be used between 5 and 10 days.

– said János Slavik, who stressed that the drug is still in the clinical trial phase, it has not yet been registered as an anti-coronavirus agent.

The specialist confirmed that the right amount of Avigan is available so that any patient who needs it can get it.

As academician Miklós György Keserű, head of the Pharmaceutical Chemistry Research Group at the Natural Sciences Research Center, said, more research on the drug will be carried out at the Medical University with four clinical centers and the National Institute of Early Pneumology. The purpose of clinical trials is to support the efficacy of the drug at home, after which faviraprir can be fully licensed.

The five health centers will first use the drug from Japan to treat hundreds of mild to moderate coronavirus-infected patients.

The full authorization procedure lasts from 6 to 12 months, but, with temporary authorization, the product can reach Hungarian patients during testing. “

– said Miklós György Keserű, who added that research in Japan has confirmed that the drug is effective even in coronavirus patients with incipient pneumonia.

On average, it clears the coronavirus from the human body in about six days and helps improve clinical symptoms in an average of twelve days. This means that the fever, shortness of breath and cough go away, so no intensive care is needed. stressed the academic.

The clinical trial of the drug favipiravir Avigan may begin for the first time in the country at the clinic of the University of Szeged.



The number of independent publishing offices of power is steadily declining, and those that still exist are trying to stay afloat with a growing headwind. At HVG we persevere, we do not give in to pressure and we bring national and international news every day.

That is why we ask you, our readers, to support us, support us, join our membership and renew it!

And we promise to keep doing our best for you in all circumstances!

One of Fujifilm's drugs also appears to treat coronavirus patients.


hvg.hu
Technology

The drugs called Avigan and Favipiravir were developed in 2014 by a Japanese company known primarily for its cameras and photographic supplies. Now it has been found that one of the ingredients in the formulations is also good against coronavirus.

Starting in autumn, one of Fujifilm's coronavirus drugs can also be manufactured in Hungary


MTI / hvg.hu
Technology

The active substance favipiravir has already been used successfully in Asia in people with coronavirus infections. Its production is also supported by the Hungarian state.